A groundbreaking stem cell therapy offers new hope for type 1 diabetes, with early results showing potential for insulin ...

Santa Barbara, CA (January 27, 2025) — Sansum Diabetes Research Institute (SDRI) proudly announces that Dr. Francine Kaufman, ...

SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.

Heart disease is once again the leading cause of death in the U.S., according to a new statistical report from the American ...

Findings indicate a 12.8% 10-year diabetes risk, driven by fasting plasma glucose, age, sex, and BMI, highlighting the need ...

Heart disease remains the top killer of Americans as risk factors continue to grow. Get the latest statistics from the ...

Comprehensive study exposes critical health risks of obesity, including diabetes, heart disease, and cancer, while offering ...

This study reinforces the significance of intensive glycaemic control and is a paradigm shift in managing the disease and its ...

NIH is the largest public funder of biomedical research in the world investing more than $40 billion in research yearly, $7 billion going to cancer research, which is crucial to supporting ongoing ...

The good news is that the risk for thyroid cancer linked to GLP-1 drugs appears low, but higher detections in the first year, ...

New Delhi: Sun Pharma Labs has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug ...

An observational analysis has found that the drugs may lower the risk of substance abuse and cognitive issues. But the ...